[{"Assets_0_Q3_USD":57246000000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":210000000.0,"NetIncomeLoss_1_Q3_USD":-314000000.0,"NetIncomeLoss_3_Q3_USD":-1108000000.0,"StockholdersEquity_0_Q3_USD":13790000000.0,"EarningsPerShareBasic_1_Q3_USD":-0.29,"EarningsPerShareBasic_3_Q3_USD":-1.02,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":1092000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":1091000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-Q","period":"20190930","fy":"2019.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20191107"}]